Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database.

Ma, Shizhan; Liu, Shudong; Wang, Qi; Chen, Lijuan; Yang, Ping; Sun, Huihuan

Ma, Shizhan; Liu, Shudong; Wang, Qi; Chen, Lijuan; Yang, Ping; Sun, Huihuan.

Affiliation

Ma S; Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
Liu S; Department of Endocrinology, Shandong Rongjun General Hospital, Jinan, Shandong, China.
Wang Q; Department of Pharmacy, The Fifth People's Hospital of Jinan, Jinan, Shandong, China.
Chen L; Department of Endocrinology, Shandong Rongjun General Hospital, Jinan, Shandong, China.
Yang P; Department of Endocrinology, Shandong Rongjun General Hospital, Jinan, Shandong, China.
Sun H; Department of Endocrinology, Shandong Rongjun General Hospital, Jinan, Shandong, China.

J Clin Pharm Ther ; 45(1): 204-207, 2020 Feb.

Article in En | MEDLINE | ID: mdl-31518450

Subject(s)

Chemical and Drug Induced Liver Injury/etiology; Fenofibrate/adverse effects; Hypolipidemic Agents/adverse effects; Aged; Chemical and Drug Induced Liver Injury/diagnosis; Chemical and Drug Induced Liver Injury/enzymology; Fenofibrate/administration & dosage; Humans; Hypertriglyceridemia/drug therapy; Hypolipidemic Agents/administration & dosage; Male; Time Factors

Key words

drug-induced liver injury; fenofibrate; hepatotoxicity; hypertriglyceridemia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Fenofibrate / Chemical and Drug Induced Liver Injury / Hypolipidemic Agents Type of study: Diagnostic_studies / Screening_studies Limits: Aged / Humans / Male Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2020 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google